- US-listed companies
- ESSA Pharma Inc.
- Income statement
ESSA Pharma Inc. (EPIX) Income statement
Market cap
$8.93M
P/E ratio
| 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Research & development | 5 | 7 | 12 | 24 | 24 | 21 | 21 |
| Operating expenses | - | - | 24 | 37 | 37 | 32 | 34 |
| Income before tax | -11,602,411 | -10,403,945 | -23,734,017 | -36,839,810 | -35,215,072 | -26,580,743 | -28,542,821 |
| Provision for income taxes | - | - | -288,647 | -34,349 | -111,821 | 1,600 | - |
| Effective tax rate (%) | - | - | - | ||||
| Net income | -11,629,440 | -10,441,865 | -23,445,370 | -36,805,461 | -35,103,251 | -26,582,343 | -28,542,821 |
| Earnings per share | - | - | - | - | -0.8 | -0.6 | -0.64 |
| Diluted EPS | - | - | - | - | -0.8 | -0.6 | -0.64 |